BRCA2 and chondrosarcoma: Other inconsistencies, such as the fact that a BRCA2 frameshift insertion in a patient with chondrosarcoma was not called in the panel due to a significantly lower TVF than in MASTER 1, are more likely due to sample preparation issues during the hybridization or enrichment process.